drugset / Trial / NCT03689413

Adequate Dosage of Sugammadex on Thyroid Surgery

NCT03689413

RandomizedParallel-groupDouble-blindPrevention

Summary

This study was designed to compare two dosage of sugammadex after tracheal intubation for optimal condition of continuous intraoperative neuromonitoring in thyroid surgery to protect recurrent laryngeal nerve.

Timeline

Start
2018-10-01
Primary completion
2019-08-28
Completion
2019-08-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 1 mg/kg Intravenous
Subject Sugammadex Other / unclassified 2 mg/kg Intravenous

Indications

No indication recorded.